ARTICLE | Clinical News
Bupivacaine: Phase II data
January 18, 2016 8:00 AM UTC
Top-line data from an open-label, Danish Phase II trial in 32 head and neck cancer patients with OM pain showed that oral BUPI plus standard anesthetic treatment met the primary endpoint of reducing p...